In Vitro Antifungal Susceptibility and Molecular Characterization of Clinical Isolates of Fusarium verticillioides ( F. moniliforme ) and Fusarium thapsinum
- 1 June 2008
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 52 (6) , 2228-2231
- https://doi.org/10.1128/aac.00176-08
Abstract
A microdilution method was used to test 11 antifungal drugs against clinical isolates of Fusarium thapsinum and three different phylogenetic clades of Fusarium verticillioides that were characterized by sequencing a region of the beta-tubulin gene. Terbinafine was the most-active drug against both species, followed by posaconazole against F. verticillioides.Keywords
This publication has 22 references indexed in Scilit:
- Fusarium Infections in Immunocompromised PatientsClinical Microbiology Reviews, 2007
- Phylogenetic Diversity and Microsphere Array-Based Genotyping of Human Pathogenic Fusaria, Including Isolates from the Multistate Contact Lens-Associated U.S. Keratitis Outbreaks of 2005 and 2006Journal of Clinical Microbiology, 2007
- Universal In Vitro Antifungal Resistance of Genetic Clades of the Fusarium solani Species ComplexAntimicrobial Agents and Chemotherapy, 2007
- Micafungin: pharmacology, experimental therapeutics and clinical applicationsExpert Opinion on Investigational Drugs, 2005
- In vitro interactions of licensed and novel antifungal drugs against Fusarium sppDiagnostic Microbiology and Infectious Disease, 2004
- Human fusariosisClinical Microbiology & Infection, 2004
- Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal InfectionsClinical Infectious Diseases, 2003
- Experimental pathogenicity of four opportunist Fusarium species in a murine modelJournal of Medical Microbiology, 1999
- Fusarium thapsinum (Gibberella thapsina): A New Species in Section Liseola from SorghumMycologia, 1997
- Opportunistic fusarial infections in humansEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995